Elmehøj Ventures
Family officeCopenhagen · Pre-Seed–Series A · 1 people tracked
Investment thesis
Elmehøj Ventures is a small family office deploying its own capital patiently into early-stage life science, medtech, and health technology companies, alongside selected fund commitments. With no LPs or fund timelines, it takes a genuinely long-term view, backing a few teams each year with modest tickets, typically alongside angels and other funds rather than leading. Its differentiation lies in deep clinical and scientific judgement drawn from decades in transplant surgery, hepatology, and translational medicine, supported by an agent-driven diligence platform. The firm focuses on the Danish and wider Nordic ecosystem, occasionally backing founders and funds elsewhere when the fit is strong.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
What they invest in
from 11 of 29 portfolio companiesBiotech ×6Healthtech ×6Medical Devices ×4AI & Machine Learning ×3Deep Tech ×2Circular Economy ×1Consumer ×1Digital Health ×1
HQs:Denmark×3Sweden×1United States×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×42 founders×53 founders×1
Investments · 29 tracked
founders shown can be your intro path
Alcolase is developing a liposomal enzyme supplement that delivers three enzymes to the stomach to break down alcohol and acetaldehyde before absorption into the bloodstream, aimed at people with ALDH2 deficiency and alcohol intolerance.
BiotechConsumerWellness & FitnessCopenhagen, DK
Mikkel Precht(Founder)in
PartnerAllan Rasmussen· solo GP
Co-investorsAda VenturesAntlerAntler AustraliaDelphinus Venture Capital
Early-stage venture investor backing founders from inception across thirty global locations.
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
Antler is a global early-stage venture capital firm that invests in founders from first check through IPO, offering capital, network, and community.
Sector Agnostic
Magnus Grimeland(Founder)in
PartnerAllan Rasmussen· solo GP
Co-investorsAC VenturesAgaeti VenturesAntler AustraliaFarvatn VentureModi VenturesPeak+3 more
Early-stage fund built around a collective of Nordic and Baltic founders.
PartnerAllan Rasmussen· solo GP
Co-investorsAspire11Wave Ventures
CathVision develops electrophysiology solutions for physicians treating cardiac arrhythmia, including the ECGenius EP recording system for cardiac signal acquisition and Cardialytics AI-based analytic tools.
AI & Machine LearningHealthtechMedical Devices
Mads Emil Matthiesen(Co-Founder & CEO)inRune Ørndrup(Co-Founder)inAllan Gersfelt-Larsen(VP Engineering)in
PartnerAllan Rasmussen· solo GP
Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers.
BiotechDeep TechHealthtechCopenhagen, DK
Jørgen(Co-founder & Chief Operating Officer)Jørgen Dam(Founder)
PartnerAllan Rasmussen· solo GP
Cerebriu develops machine learning software for medical imaging, applying AI to healthcare diagnostics.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Robert Lauritzen(Co-founder & Chief Executive Officer)Martin Lillholm(Co-founder & Chief Operating Officer)Akshay Pai(Co-founder & Chief Technology Officer)Kristine Wernerfelt(Chief Financial Officer)Zac Durant(Vice President of BD)
PartnerAllan Rasmussen· solo GP
EQT X is a large-cap buyout fund making control and co-control equity investments in mid-to-large companies.
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
EQT Group is a global private markets firm that invests and builds across private capital, infrastructure, and real estate.
Enterprise Software
Conni Jonsson(Founder and Honorary Chair)
PartnerAllan Rasmussen· solo GP
Co-investorsBCIEQT VenturesLSP (Life Sciences Partners)
Evergreen private-markets feeder vehicle giving private investors access to EQT's private equity and infrastructure funds.
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
Company positioned around injury care technology, with details pending a forthcoming website launch.
Healthtech
PartnerAllan Rasmussen· solo GP
Identical Implant develops dental implant technology.
BiotechHardwareMedical Devices
PartnerAllan Rasmussen· solo GP
Co-investorsCreative VenturesCrimson Investment Fund
InVivo develops a miniaturized pressure sensor system for continuous bladder monitoring to diagnose and manage urinary dysfunction conditions.
BiotechHealthtechMedical Devices
PartnerAllan Rasmussen· solo GP
Danish marketplace for used and surplus designer furniture to keep quality pieces in circulation.
PartnerAllan Rasmussen· solo GP
KEEPR is a curated online marketplace for design furniture, selling display models, surplus stock, and second-grade items from known brands with the same warranty as new goods.
Circular EconomyE-commerceMarketplaces
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
Copenhagen-based venture fund backing technology companies from seed to Series A across Denmark and the Nordics.
PartnerAllan Rasmussen· solo GP
RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments.
AI & Machine LearningBiotechLaguna Niguel, US
Devan ShahMichelle Lynn Hall
PartnerAllan Rasmussen· solo GP
Co-investorsBioBritPortal InnovationsService Provider Capital
Early-stage Danish diagnostics company building ahead of a public launch.
PartnerAllan Rasmussen· solo GP
Early-stage Danish life-science company building ahead of a public launch.
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
German venture capital fund of funds providing diversified access to Europe's top early-stage funds.
PartnerAllan Rasmussen· solo GP
PartnerAllan Rasmussen· solo GP
Zerion is a pharmaceutical development company that uses its Dispersome formulation technology to improve the solubility and therapeutic performance of poorly soluble drugs.
BiotechDeep TechHealthtechCopenhagen, DK
Korbinian LöbmannJorrit Water
PartnerAllan Rasmussen· solo GP
Portfolio news
latest coverage across their companiesAlcolase · thedrinksbusiness.com · May 26, 2026
Frequently asked questions
- How many investments has Elmehøj Ventures made?
- Elmehøj Ventures has 29 tracked investments.
- What stage does Elmehøj Ventures invest at?
- Elmehøj Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Elmehøj Ventures focus on?
- Elmehøj Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Elmehøj Ventures located?
- Elmehøj Ventures is headquartered in Copenhagen, DK.
- Does Elmehøj Ventures lead rounds?
- Elmehøj Ventures typically participates in rounds rather than leading them.
- Who does Elmehøj Ventures co-invest with?
- Elmehøj Ventures most often shares deals with Antler Australia, AC Ventures, Creative Ventures, among 20 tracked co-investors.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.